Search Results 301-310 of 16223 for GLP-1 agonist
If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines. Acenocoumarol; Dexamethasone ...
The purpose of this study is to collect blood samples for biomarker assessment in type 1 diabetes prior to and at specific time points during closed loop ...
Glucagon-Like Peptide-1 Agonist Use in Adults With Congenital Heart Disease: Effect, Safety, and Outcomes. JACC Adv. 2025 Apr; 4(4):101674. Epub 2025 Mar 24 ...
Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in ...
The purpose of this study is to investigate the safety and tolerability of two dose regimens of IFX-1 as add-on to standard of care (SOC) in subjects with GPA ...
About this study. This study is researching an experimental drug called REGN7544 (called "study drug"). The study is focused on participants with POTS.
A nurse or other trained health professional will give you or your child this medicine in a hospital. This medicine is given through a needle placed in one of ...
Mayo Clinic researchers have developed a genetic test that can help predict how people will respond to weight loss medications such as GLP-1s. ... 1 · 2 · 3 · 4 ...
A Safety Extension Study With Benralizumab for Asthmatic Adults on Inhaled Corticosteroid Plus Long-acting β2 Agonist ... 1 trial. Phase 4 trials look at long- ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!